Cingulate Inc. (CING) stock
CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$5.11+0.39 (+8.26%)
Close on Nov 18, 2026Market cap $74.31MP/E –Yield –
Cingulate free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Cingulate's free cash flow for the twelve months ending Jun 30, 2026 was -$20.94M. For fiscal 2025 it was -$17.41M. The highest annual figure on record is -$7.21M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$17.41M | – |
| FY2024 | Dec 31, 2024 | -$18.66M | – |
| FY2023 | Dec 31, 2023 | -$15.26M | – |
| FY2022 | Dec 31, 2022 | -$16.04M | – |
| FY2021 | Dec 31, 2021 | -$11.25M | – |
| FY2020 | Dec 31, 2020 | -$7.21M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.97M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.97M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.75M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.24M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.28M | – |
| Q1 FY2024 | Mar 31, 2024 | -$8.83M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.75M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.29M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.60M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.61M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.35M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.40M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.41M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.87M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.33M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.60M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.57M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.74M | – |
See a number that looks wrong?